Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report

    January 2025 in “ Clinical Case Reports ”
    Sunil Bogati, Kajal Bishwakarma, Sunil Bogati, Saket Jha, Sunil Bogati, Saket Jha
    TLDR Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.
    This case report discusses a 36-year-old Nepalese female with adult-onset Still's disease (AOSD) who presented with symptoms including fever, joint pain, rash, hair loss, and weight loss, and was diagnosed with macrophage activation syndrome (MAS), a severe complication of AOSD. Despite initial treatment with IV steroids, her condition required further intervention with dexamethasone and cyclosporine, which led to improvement. The report highlights the critical nature of MAS, which occurs in about 15% of AOSD patients and has a mortality rate over 50%, emphasizing the importance of timely and aggressive treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community You will lose hair if your prostaglandins aren't in balance

      in Research/Science  56 upvotes 11 months ago
      Prostaglandin balance affects hair loss, particularly in conditions like Lichen Planopilaris, where an imbalance can lead to hair follicle damage. Treatments mentioned include prostaglandin analogs and Pioglitazone HCL, with a focus on maintaining prostaglandin equilibrium for potential hair regrowth.

      community Verteporfin and Microneedling

      in Treatments 1 year ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  52 upvotes 1 year ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community .3% Dut and 8% Min: Hair Loss Returns after 8 months

      in Update  1 upvotes 3 days ago
      Hair loss returned after 8 months of using a treatment with .3% Dutasteride and 8% Minoxidil. The user suspects a marketing strategy as the company offers a more expensive product with additional ingredients like biotin and finasteride.

    Similar Research

    5 / 1000+ results